Martin Stockler

Summary

Affiliation: University of Sydney
Country: Australia

Publications

  1. pmc Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer
    M R Stockler
    Department of Medical Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050 Australia
    Br J Cancer 94:208-12. 2006
  2. ncbi request reprint Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial
    Martin Stockler
    Department of Medicine and School of Public Health, NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia
    J Clin Oncol 22:3389-94. 2004
  3. ncbi request reprint Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial
    Martin R Stockler
    NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia
    Lancet Oncol 8:603-12. 2007
  4. ncbi request reprint Ovarian suppression for early breast cancer
    Nicholas Wilcken
    Department of Medical Oncology, Westmead and Nepean Hospitals and University of Sydney, NSW 2145, Australia
    Lancet 369:1668-70. 2007
  5. ncbi request reprint Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancer
    A M Joshua
    Department of Medical Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
    Intern Med J 35:468-72. 2005
  6. ncbi request reprint Evidence-based medicine: useful tools for decision making
    J C Craig
    Department of Public Health and Community Medicine, University of Sydney, NSW
    Med J Aust 174:248-53. 2001
  7. ncbi request reprint Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer
    A K Nowak
    National Health and Medical Research Centre Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia
    Lancet Oncol 5:372-80. 2004
  8. doi request reprint Historical cross-trial comparisons for competing treatments in advanced breast cancer--an empirical analysis of bias
    C K Lee
    NHMRC Clinical Trials Centre, University of Sydney, NSW 1450, Australia
    Eur J Cancer 46:541-8. 2010
  9. pmc Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer
    C K Lee
    NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia
    Br J Cancer 102:1341-7. 2010
  10. ncbi request reprint Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?
    V M Duric
    NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW 2050, Australia
    Ann Oncol 16:1786-94. 2005

Collaborators

Detail Information

Publications31

  1. pmc Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer
    M R Stockler
    Department of Medical Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050 Australia
    Br J Cancer 94:208-12. 2006
    ..Ranges based on simple multiples of the predicted survival time appropriately convey prognosis and its uncertainty in newly referred people with incurable cancer...
  2. ncbi request reprint Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial
    Martin Stockler
    Department of Medicine and School of Public Health, NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia
    J Clin Oncol 22:3389-94. 2004
    ..To determine whether adding regular acetaminophen (paracetamol) could improve pain and well-being in people with advanced cancer and pain despite strong opioids...
  3. ncbi request reprint Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial
    Martin R Stockler
    NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia
    Lancet Oncol 8:603-12. 2007
    ..We aimed to identify the effects of an established antidepressant on these symptoms and survival in patients with advanced cancer who did not have major depression as assessed by clinicians...
  4. ncbi request reprint Ovarian suppression for early breast cancer
    Nicholas Wilcken
    Department of Medical Oncology, Westmead and Nepean Hospitals and University of Sydney, NSW 2145, Australia
    Lancet 369:1668-70. 2007
  5. ncbi request reprint Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancer
    A M Joshua
    Department of Medical Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
    Intern Med J 35:468-72. 2005
    ..However no phase II trials have clearly defined the level of activity of docetaxel after mitozantrone...
  6. ncbi request reprint Evidence-based medicine: useful tools for decision making
    J C Craig
    Department of Public Health and Community Medicine, University of Sydney, NSW
    Med J Aust 174:248-53. 2001
    ..Computer-assisted decision support tools for clinicians facilitate integration of individual patient data with the best available research data...
  7. ncbi request reprint Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer
    A K Nowak
    National Health and Medical Research Centre Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia
    Lancet Oncol 5:372-80. 2004
    ..Longer follow-up of these trials and results from continuing trials are needed to clarify the best use of taxanes in early breast cancer...
  8. doi request reprint Historical cross-trial comparisons for competing treatments in advanced breast cancer--an empirical analysis of bias
    C K Lee
    NHMRC Clinical Trials Centre, University of Sydney, NSW 1450, Australia
    Eur J Cancer 46:541-8. 2010
    ..We also examine the extent to which statistical adjustment for baseline characteristics can account for inter-trial differences in outcomes...
  9. pmc Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer
    C K Lee
    NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia
    Br J Cancer 102:1341-7. 2010
    ..Baseline health-related quality of life (QL) is associated with survival in advanced breast cancer. We sought to identify patients who were less likely to respond to chemotherapy and at greater risk of toxicity on the basis of their QL...
  10. ncbi request reprint Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?
    V M Duric
    NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW 2050, Australia
    Ann Oncol 16:1786-94. 2005
    ..Indications, regimens and supportive care have changed. We sought the preferences of contemporary women who received similar chemotherapy...
  11. doi request reprint The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study
    Allan ben Smith
    Psycho oncology Co operative Research Group PoCoG, University of Sydney, Sydney, Australia
    Psychooncology 22:2557-64. 2013
    ..This cross-sectional study aimed to identify the prevalence and correlates of supportive care needs in testicular cancer (TC) survivors...
  12. doi request reprint Outcomes of permanent peritoneal ports for the management of recurrent malignant ascites
    Nicholas Anthony Coupe
    Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, Australia
    J Palliat Med 16:938-40. 2013
    ..Percutaneous drainage relieves symptoms in the vast majority of patients. The aim of this study was to determine the course and outcomes in a consecutive series of patients with recurrent ascites managed with permanent peritoneal ports...
  13. ncbi request reprint Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile?
    Prunella Blinman
    NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
    Eur J Cancer 46:1800-7. 2010
    ....
  14. pmc Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?
    V M Duric
    NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
    Br J Cancer 93:1319-23. 2005
    ....
  15. ncbi request reprint Hospitalised patients' views on doctors and white coats
    B R Gooden
    Faculty of Medicine, University of Sydney, NSW
    Med J Aust 175:219-22. 2001
    ..The recognition, symbolism and formality afforded by a white coat may enhance communication and facilitate the doctor-patient relationship...
  16. doi request reprint Symptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory/resistant ovarian cancer
    Michael Friedlander
    Prince of Wales Hospital, Sydney, New South Wales, Australia
    Int J Gynecol Cancer 19:S44-8. 2009
    ..In addition, this study will give us an insight into how all patients are managed rather than a select minority who are treated in clinical trials...
  17. ncbi request reprint Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer
    Paul Glare
    Department of Palliative Care, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia
    Support Care Cancer 12:432-40. 2004
    ..To systematically review studies of antiemetics used in the treatment of nausea in patients with far-advanced cancer...
  18. ncbi request reprint Beauty is in the eye of the examiner: reaching agreement about physical signs and their value
    A M Joshua
    Department of Medical Oncology, Sydney Cancer Centre, Sydney, New South Wales, Australia
    Intern Med J 35:178-87. 2005
    ..We provide a selected summary of the reliability and accuracy as well as important messages of key findings in the physical examination...
  19. ncbi request reprint The benefits and costs of tamoxifen for breast cancer prevention
    Simon D Eckermann
    National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown NSW, 1450
    Aust N Z J Public Health 27:34-40. 2003
    ..To estimate the effects of key uncertainties on the effectiveness and cost-effectiveness of breast cancer prevention with tamoxifen...
  20. ncbi request reprint Fulvestrant: spreading the word, but not too thinly
    Nicholas R C Wilcken
    NSW Breast Cancer Institute and Department of Medical Oncology, Westmead Hospital, NSW, Sydney, Australia
    Lancet 362:1254. 2003
  21. doi request reprint Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer
    Vlatka M Duric
    NHMRC Clinical Trials Centre, University of Sydney, NSW, Australia
    Patient Educ Couns 72:239-45. 2008
    ..Preferences of women who had completed adjuvant chemotherapy for early breast cancer were compared with those of their partners by determining the smallest benefits they judged sufficient to make adjuvant chemotherapy worthwhile...
  22. ncbi request reprint Quality of life and adjuvant systemic therapy for early-stage breast cancer
    Peter S Grimison
    NHMRC Clinical Trials Centre, Building M02F, University of Sydney, NSW 2006, Australia
    Expert Rev Anticancer Ther 7:1123-34. 2007
    ..New technologies will make HRQL information increasingly available for individual patient care...
  23. ncbi request reprint Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module
    Anna K Nowak
    NHRMC, Clinical Trial Centre, University of Sydney, Locked Bag 77, Camperdown NSW 1450 Australia
    J Clin Oncol 22:3172-80. 2004
    ....
  24. ncbi request reprint Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer
    Vlatka M Duric
    NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
    Psychooncology 16:48-59. 2007
    ..We sought to better understand such preferences by assessing associations between preferences and psychosocial factors, and by asking women who judged negligible benefits sufficient to explain why...
  25. ncbi request reprint Predicting the toxicity of weekly docetaxel in advanced cancer
    Kellie A Charles
    Department of Pharmacology, University of Sydney, Sydney, NSW, Australia
    Clin Pharmacokinet 45:611-22. 2006
    ..To determine the safety profile of 40 mg/m(2) docetaxel administered weekly to a mixed population of advanced cancer patients and identify predictors of toxicity and survival following treatment with weekly docetaxel in this population...
  26. ncbi request reprint Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review
    Catherine A Hauser
    Sydney Cancer Centre, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW, 2050, Australia
    Support Care Cancer 14:999-1011. 2006
    ..To review the literature and develop a conceptual framework about prognostic factors for people presenting to medical oncologists with recently diagnosed incurable cancer...
  27. ncbi request reprint Health status rated with the Medical Outcomes Study 36-Item Short-Form Health Survey after spinal cord injury
    Mark J Haran
    Dept of Aged Care and Rehabilitation Medicine, Royal North Shore Hospital, Sydney, Australia
    Arch Phys Med Rehabil 86:2290-5. 2005
    ..To describe the health status of Australians with spinal cord injury (SCI)...
  28. ncbi request reprint Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review
    Anna K Nowak
    National Health and Medical Research Council NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia
    Cancer 103:1408-14. 2005
    ..The authors conducted a systematic review of randomized clinical trials to compare the effect of a tamoxifen-containing arm with a nontamoxifen-containing arm in advanced HCC...
  29. ncbi request reprint What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?
    Belinda Thewes
    Prince of Wales Hospital, Randwick, Sydney, Australia
    Lancet Oncol 6:581-8. 2005
    ..We aimed to quantify the survival gains that premenopausal patients with early-stage breast cancer require to justify the side-effects and inconvenience of adjuvant endocrine treatments...
  30. ncbi request reprint Achieving equal standards in medical student education: is a national exit examination the answer?
    Bogda Koczwara
    Medical Oncology, Flinders Medical Centre, Flinders Drive, Bedford Park, SA 5042, Australia
    Med J Aust 182:228-30. 2005
    ..Such an examination could assess medical school outcomes, monitor the effects of curriculum change, and provide a benchmark for new medical schools that would help medical curricula evolve to better meet society's needs...
  31. ncbi request reprint Measuring men's opinions of prostate needle biopsy
    Jessica C C Medd
    Concord Prostate Centre, Concord Hospital, Sydeny, New South Wales, Australia
    ANZ J Surg 75:662-4. 2005
    ....